Browsing Centre for Haemato-Oncology by Subject "TUSC3"
Now showing items 1-1 of 1
-
Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer.
(2017-10-17)Colorectal cancer (CRC) is a biologically and clinically heterogeneous disease. Even though many recurrent genomic alterations have been identified that may characterize distinct subgroups, their biological impact and ...